RecruitingNCT05909267
L-dopa or placebo for motivation and movement in depression with inflammation
About this title
Read the official source — NCT05909267Medication studyAges 18–65Germany
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- SteglitzSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 26, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 165
- Sponsor
- Charite University, Berlin, Germany
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05909267
- Official title
Show the full official title
Effects of Pharmacological Dopamine Modulation on Motivation and Motor Function in Major Depression Characterized by Low-grade Inflammation.
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Steglitz
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Charite University, Berlin, Germany, a university.
Does this study involve medication?
Yes. The study involves medication, including L-dopa/Carbidopa and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
